Human Metabolome Technologies 

¥699
0
-¥4-0.57% Today

Statistics

Day High
705
Day Low
698
52W High
869
52W Low
631
Volume
6,500
Avg. Volume
9,270
Mkt Cap
4.14B
P/E Ratio
23.2
Dividend Yield
2.56%
Dividend
17.9

Upcoming

Dividends

2.56%Dividend Yield
Sep 25
¥15
Sep 24
¥15
Sep 23
¥10
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
21.64%
1Y Growth
20%

Earnings

13MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-17.88
-0.28
17.33
34.93
Expected EPS
N/A
Actual EPS
N/A

Financials

18.91%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
3.62BRevenue
685.04MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 6090.TSE. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Human Metabolome Technologies, Inc., biotechnology company, develops metabolomics technologies and solutions for drug discovery, diagnosis, and food production in Japan. The company provides metabolome analysis services; and global profiling, targeted assays, flux analysis, and lipidomics services. It also develops biomarkers, such as Phosphorylethanolamine, a biomarker for major depressive disorder and measured in blood plasma. The company offers solutions for cancer metabolism, metabolic flux analysis, infectious diseases, basic science, preclinical and clinical, food and nutrition, and microbiome applications. It has a collaboration with the Institute for Advanced Biosciences and Keio University for the development of metabolome analysis technology. The company was incorporated in 2003 and is headquartered in Tsuruoka, Japan.
Show more...
CEO
Mr. Katsuhito Hashizume
Country
JP
ISIN
JP3794530000

Listings

0 Comments

Share your thoughts

FAQ

What is Human Metabolome Technologies stock price today?
The current price of 6090.TSE is ¥699 JPY — it has decreased by -0.57% in the past 24 hours. Watch Human Metabolome Technologies stock price performance more closely on the chart.
What is Human Metabolome Technologies stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Human Metabolome Technologies stocks are traded under the ticker 6090.TSE.
What is Human Metabolome Technologies market cap?
Today Human Metabolome Technologies has the market capitalization of 4.14B
When is the next Human Metabolome Technologies earnings date?
Human Metabolome Technologies is going to release the next earnings report on May 13, 2026.
What were Human Metabolome Technologies earnings last quarter?
6090.TSE earnings for the last quarter are 24.22 JPY per share, whereas the estimation was N/A JPY resulting in a N/A surprise. The estimated earnings for the next quarter are N/A JPY per share.
What is Human Metabolome Technologies revenue for the last year?
Human Metabolome Technologies revenue for the last year amounts to 3.62B JPY.
What is Human Metabolome Technologies net income for the last year?
6090.TSE net income for the last year is 685.04M JPY.
Does Human Metabolome Technologies pay dividends?
Yes, 6090.TSE dividends are paid semi-annual. The last dividend per share was 15 JPY. As of today, Dividend Yield (FWD)% is 2.56%.
In which sector is Human Metabolome Technologies located?
Human Metabolome Technologies operates in the Healthcare sector.
When did Human Metabolome Technologies complete a stock split?
Human Metabolome Technologies has not had any recent stock splits.
Where is Human Metabolome Technologies headquartered?
Human Metabolome Technologies is headquartered in Tsuruoka, JP.